Searching accross hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Nature medicine | Feb 7, 2011

Hyperglycemia is associated with greater hematoma expansion and poor clinical outcomes after intracerebral hemorrhage. We show that cerebral hematoma expansion triggered by intracerebral infusion of autologous blood is greater in diabetic rats and mice compared to nondiabetic controls and that this augmented expansion is ameliorated by plasma kallikrein (PK) inhibition or deficiency. Intracerebral injection of purified PK augmented hematoma expansion in both diabetic and acutely hyperglycemic rats, whereas injection of bradykinin, plasmin or tissue plasminogen activator did not elicit such a response. This response, which occurs rapidly, was prevented by co-injection of the glycoprotein VI agonist convulxin and was mimicked by glycoprotein VI inhibition or deficiency, implicating an effect of PK on inhibiting platelet aggregation. We show that PK inhibits collagen-induced platelet aggregation by binding collagen, a response enhanced by elevated glucose concentrations. The effect of hyperglycemia on hematoma expansion and PK-mediated inhibition of platelet aggregation could be mimicked by infusing mannitol. These findings suggest that hyperglycemia augments cerebral hematoma expansion by PK-mediated osmotic-sensitive inhibition of hemostasis.

Pubmed ID: 21258336 RIS Download

Mesh terms: Animals | Blood-Brain Barrier | Brain | Cerebral Hemorrhage | Diabetes Mellitus, Experimental | Hematoma | Hyperglycemia | Injections, Intraventricular | Mice | Mice, Inbred C57BL | Plasma Kallikrein | Plasminogen | Platelet Aggregation | Rats | Rats, Sprague-Dawley

Research resources used in this publication

None found

Research tools detected in this publication

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: P01 HL087203
  • Agency: NHLBI NIH HHS, Id: HL090132
  • Agency: NEI NIH HHS, Id: EY19029
  • Agency: NEI NIH HHS, Id: R01 EY019029
  • Agency: NIDDK NIH HHS, Id: P30 DK036836
  • Agency: NHLBI NIH HHS, Id: R43 HL090132
  • Agency: NHLBI NIH HHS, Id: HL87203
  • Agency: NEI NIH HHS, Id: R01 EY019029-03
  • Agency: NHLBI NIH HHS, Id: HL07917
  • Agency: NHLBI NIH HHS, Id: T32 HL007917
  • Agency: NIDDK NIH HHS, Id: DK36836

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.

Jackson Laboratory

An independent, nonprofit organization focused on mammalian genetics research to advance human health. Their mission is to discover the genetic basis for preventing, treating, and curing human disease, and to enable research for the global biomedical community. Jackson Laboratory breeds and manages colonies of mice as resources for other research institutions and laboratories, along with providing software and techniques. Jackson Lab also conducts genetic research and provides educational material for various educational levels.


View all literature mentions